Asahi Songwon Q4 FY26: Margin rebound in blue pigments, and a steadier base for Azo and APIs

Asahi Songwon Colors Limited closed Q4 FY26 with a sharp improvement in profitability, even as the full-year revenue remained lower than the prior year. On a consolidated basis, revenue from operations in Q4 FY26 stood at INR 144.05 crore, down 5.70% year on year but up 19.40% sequentially. EBITDA (including other income) jumped to INR 23.02 crore with a 15.60% margin, and profit after tax rose to INR 10.82 crore.

For FY26, consolidated revenue from operations was INR 535.48 crore versus INR 562.36 crore in FY25. Despite that decline, profit before tax (excluding exceptional items) increased slightly to INR 25.56 crore and PAT rose to INR 17.78 crore. Management also highlighted continued deleveraging, with FY26 interest cost reducing to INR 12.24 crore from INR 16.47 crore.

Blue pigments: Realizations did the heavy lifting

Management described Q4 FY26 as a strong quarter for the phthalocyanine blue pigment business. The key point was that volume growth was modest, and the improvement was largely driven by better realizations. Higher raw material prices, influenced by geopolitical volatility, were passed through to customers. Management attributed the company’s ability to do this to long-standing supplier and customer relationships.

Alongside pricing, management reiterated that internal operational efficiency initiatives are underway and have already started contributing to results. They did not provide project-level specifics or quantify the impact, but stated that this work should strengthen margins more sustainably over coming periods.

One caveat was the unusually low power and fuel cost ratio in Q4. Management clarified that this was partly due to a one-time benefit related to renewable energy billing. They said a rebate that had been pending for two years was received in a single quarter, and that the same magnitude should not be assumed going forward.

Azo pigments: EBITDA positive in FY26; expansion plan linked to utilization

The Azo pigments business remains a growth focus, supported by the broader China+1 narrative and the intent to serve customers looking to diversify supply chains away from China. In the earnings call, management said the Azo segment achieved EBITDA positivity and cash break-even for the full year.

A specific segment datapoint was also shared during Q&A: full-year Azo revenue was INR 78 crore, while PBT was minus INR 2.42 crore. Management indicated that breaking even at the PBT level is an expectation for next year.

On capacity, management stated that utilization is around 65% and they aim to move toward 75% to 85% over the next 3 to 4 quarters. Once that threshold is reached, they may initiate a capacity expansion.

Financial snapshot (consolidated)

Note: EBITDA includes other income as per company disclosure.

APIs (Atlas): Volumes grew, realizations are turning

The API business continues to be shaped by the gap between volume growth and price realizations. Management said the API business delivered around 18% CAGR volume growth over the last three years, but a steep drop in realizations since acquisition prevented this from translating into stronger reported revenue.

During the call, the company provided a quantified view on Pregabalin pricing. Management said prices have dropped around 40% to 45% since acquisition, but from the bottom have improved by about 15%. They also stated that Pregabalin contributes around 60% to 70% of the API business.

A key operational data point was Chattral utilization. Management indicated intermediate utilization is around 70% (and in another answer referenced intermediates around 60%), while finished API utilization remains low at around 30%. This is the area the company sees as the major opportunity to improve fixed asset turnover.

On regulatory progress, management reiterated that they are working toward CEP certification by the end of the current financial year, a milestone they believe can enable access to more profitable export segments.

What to track from here

First, the durability of the blue pigments margin improvement matters. Management indicated Q1 should be able to maintain Q4-level margins across segments and they will attempt to improve further, but the operating environment remains volatile.

Second, Azo’s path to sustained profitability is now linked to utilization moving into the 75% to 85% range and the planned INR 10 to 15 crore expansion that could lift capacity by about 1.5 times. Third, for Atlas, the combination of pricing recovery, CEP progression, and better finished API utilization at Chattral will determine whether the business can deliver the margin targets discussed by management.

The quarter was a reminder that Asahi Songwon’s financial profile is currently driven by the execution strength of the blue pigments business, while the Azo and API businesses are still in the transition from stability to scale.